AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations
Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited an open-platform innovative company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, today announced a series of…
